The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing. Continuous processing for the production of key building blocks and intermediates for ...
Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing. While most basic research occurs in academia, contributions from industry are also undeniably ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback